Fabrazyme (Agalsidase Beta)

Fabrazyme (agalsidase beta) for injection is the only enzyme replacement therapy (ERT) used for the treatment of adult and pediatric patients aged 24 months and older with confirmed Fabry disease.

Recommended Dosage: The recommended dosage of Fabrazyme injection is 1 mg/kg body weight administered every 2 weeks as an intravenous (IV) infusion. The initial recommended infusion rate is 0.25 mg/min (15 mg/hour). Do not infuse this therapeutic drug in the same intravenous line with other medicinal products.

• Hypersensitivity reactions, including anaphylaxis, may occur in patients treated with enzyme replacement therapies, including Agalsidase beta 5 mg/35 mg. Stop treatment immediately if reactions occur. Premedicate and closely monitor patients during infusions to manage and minimize the risk of hypersensitivity reactions.
• The formation of anti-drug antibodies, including neutralizing antibodies, has been noticed. Regularly monitor patients for antibody formation, which may scale down Fabrazyme’s effectiveness or increase the probability of infusion-related reactions.
• Limited data are available on the use of Fabrazyme injection during pregnancy. Administer it only if the probable benefits outweigh the risks to the fetus. Discuss other potential options with pregnant patients before starting therapy.
• It is unknown if this medicinal product is excreted in human milk. Caution is required when using this medicine to breastfeeding mothers, weighing the benefits of treatment against the potential risk to the nursing infant.
• The most commonly noticed symptoms include fever, chills, and nausea. Scale down the infusion rate or provide symptomatic treatment as required to manage reactions and ensure patient comfort.

What documents are required to import FABRAZYME to India?

FABRAZYME (agalsidase beta) for injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is FABRAZYME available in India?

FABRAZYME (agalsidase beta injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Fabrazyme in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

FABRAZYME can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of FABRAZYME (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Fabrazyme 5 mg/35 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the FABRAZYME (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Fabrazyme®?

Agalsidase beta is a Generic Name for the trade name drug Fabrazyme®.

What is the Manufacturer's Name of Fabrazyme®?

Fabrazyme® is manufactured by Genzyme Corporation.

Is Fabrazyme® approved by the FDA?

Yes, Fabrazyme® is approved by the FDA. Date of first approval: April 24, 2003.

What is the dosage and form of Fabrazyme® supplied?

Fabrazyme® is supplied for injection: 5 mg/35 mg of agalsidase beta as a lyophilized powder or cake in a single-dose vial for reconstitution for intravenous (IV) use.

What are the most common side effects of Fabrazyme®?

The most common side effects of Fabrazyme® are chills, upper respiratory tract infection, rash pyrexia, headache, fatigue, cough, peripheral edema, paresthesia, and dizziness.

How much does Fabrazyme® (agalsidase beta) injection cost in India?

Prices of Fabrazyme may vary over time due to market dynamics and regulatory changes. For accurate and latest information on Fabrazyme 5 mg/35 mg injection cost in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Fabrazyme® be available in SAARC countries?

Apart from Gulf countries, Fabrazyme® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Fabrazyme® injections in these countries, ensuring legal access to this medication through legal and reliable channels.

Is it safe to buy Fabrazyme® (agalsidase beta) injections online in India?

Yes, one can buy Fabrazyme 5 mg/35 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Fabrazyme® injections through legal channels.

What are the storage conditions of Fabrazyme® (agalsidase beta) injections?

Refrigerate vials at 2 to 8°C (36 to 46°F). Do not use this medicinal product after the expiration date on the vial.